| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CHEM.201604903 |
| P698 | PubMed publication ID | 27935144 |
| P50 | author | Michael Ott | Q57008971 |
| Nadja C. Bigall | Q57394191 | ||
| P2093 | author name string | Yu Xie | |
| Andreas Kirschning | |||
| Asha Balakrishnan | |||
| David Candito | |||
| Jan Frederick Miethe | |||
| Katja Seidel | |||
| Liang-Liang Wang | |||
| P2860 | cites work | Functionalisation of magnetic nanoparticles for applications in biomedicine | Q56058016 |
| The Stille Reaction, 38 Years Later | Q56482541 | ||
| A Small-Molecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing Tumors | Q57911941 | ||
| Ansamitocin, a group of novel maytansinoid antibiotics with antitumour properties from Nocardia | Q59080536 | ||
| Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications | Q29615464 | ||
| Mutational biosynthesis--a tool for the generation of structural diversity in the biosynthesis of antibiotics | Q33211659 | ||
| Total synthesis approaches to natural product derivatives based on the combination of chemical synthesis and metabolic engineering | Q33301352 | ||
| Recent developments in the maytansinoid antitumor agents | Q35622324 | ||
| Design and Application of Magnetic-based Theranostic Nanoparticle Systems | Q36940177 | ||
| Potent antibody drug conjugates for cancer therapy | Q37469585 | ||
| Merging chemical synthesis and biosynthesis: a new chapter in the total synthesis of natural products and natural product libraries | Q37996334 | ||
| Preparation of thermocleavable conjugates based on ansamitocin and superparamagnetic nanostructured particles by a chemobiosynthetic approach | Q38944991 | ||
| Efficacy of anti-RON antibody Zt/g4-drug maytansinoid conjugation (Anti-RON ADC) as a novel therapeutics for targeted colorectal cancer therapy | Q38949778 | ||
| Magnetically triggered dual functional nanoparticles for resistance-free apoptotic hyperthermia | Q39053731 | ||
| Combined muta- and semisynthesis: a powerful synthetic hybrid approach to access target specific antitumor agents based on ansamitocin P3. | Q39428470 | ||
| Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. | Q39672199 | ||
| Tumor delivery and in vivo processing of disulfide-linked and thioether-linked antibody-maytansinoid conjugates | Q39778685 | ||
| Disulfide-linked antibody-maytansinoid conjugates: optimization of in vivo activity by varying the steric hindrance at carbon atoms adjacent to the disulfide linkage. | Q53259778 | ||
| Applications of magnetic nanoparticles in biomedicine | Q56031415 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2265-2270 | |
| P577 | publication date | 2016-12-09 | |
| P1433 | published in | Chemistry—A European Journal | Q898737 |
| P1476 | title | A Bio-Chemosynthetic Approach to Superparamagnetic Iron Oxide-Ansamitocin Conjugates for Use in Magnetic Drug Targeting | |
| P478 | volume | 23 |
| Q40183635 | Synthesis of Magnetic-Nanoparticle/Ansamitocin Conjugates-Inductive Heating Leads to Decreased Cell Proliferation In Vitro and Attenuation Of Tumour Growth In Vivo. | cites work | P2860 |
Search more.